Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors (NCT07671534)
GEMINI: Phase II Study Using Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors
🩺 Plain-English Summary (8th-Grade Level)
This is an open label phase II study using metronomic low-dose gemcitabine and mitomycin c given intravenously, and thalidomide administered orally, for patients with advanced solid tumors.
Who can join: Review the eligibility criteria below.
Location: Sarcoma Oncology Research Center / Cancer Center of Southern California — Santa Monica, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Sarcoma Oncology Research Center / Cancer Center of Southern California — Santa Monica, California
📞 Contact the Study Coordinator
Phone: (310) 552-9999
Email: egordon@sarcomaoncology.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Solid Tumor Cancer
- Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing — Detroit, Michigan
- A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer — New York, New York
- BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) — San Francisco, California
- AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) — Gilbert, Arizona
Explore by condition: All Solid Tumor Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.